Healthcare Magazine November 2017 | Page 147

CANADA

The appropriate use of diagnostic tests has become a significant topic of conversation among the international medical community . A 2015 study published in the Academic Emergency Medicine Journal found that over 85 per cent of respondents believed too many diagnostic tests are ordered in their own emergency departments , and 97 % said at least some of the advanced imaging studies they personally ordered were medically unnecessary .

on our track record of being accredited by the Manitoba Quality Assurance Program ( MANQAP ) and College of American Pathologists ( CAP ), which is one of the highest ranked accreditation agencies for medical laboratories in the world .”
Significant investment By creating such efficiencies , DSM has been able to increase investments in other areas . “ By eliminating unnecessary testing we ’ ve been able to redirect resources and significantly invest in genetic testing , which is one of the biggest challenges we are facing today ,” Slater observes .
“ The future of diagnostics is becoming very genetics-based .
There are drugs , for example , which will not work if you do not have the right gene , gene combination , gene expression or gene inhibitor . A major challenge for everyone across the world , frankly , is how do we keep up with the science of genetics with high quality , reproducible genetic testing ? Many cancers now are not only diagnosed or staged simply on traditional pathology morphology , but are now using genetics to differentiate them .”
A broad mandate Of course , as a province-wide provider of diagnostics services , DSM has not solely invested in genomics . “ We ’ ve made a significant investment , between
www . healthcareglobal . com 147